Rheumatoid Arthritis Research Studies
The Division of Rheumatology strives to understand more about rheumatoid arthritis (RA) through research. Please see the list below, which summarizes the studies available to individuals interested in advancing our understanding and treatment of rheumatic disease.
| Study Name/IRB#/PI | Brief Description | Basic Eligibility Criteria | Contact |
| AMP Synovial Biopsy 15-1389 Michael Holers, MD | Biopsy of joint tissue using ultrasound | Early RA and patients transitioning between therapies due to poor response | 303-724-0581 or email Karen Franklin |
| StopRA 15-1868 Kevin Deane, MD | Use of an approved medication (hydroxychloroquine) to prevent or stop the development of RA. This study includes a placebo group. | Individuals with a positive blood test (anti-CCP antibody) or their close relatives (parents, siblings, children) | 303-724-8330 or email StopRA or visit website www.stop-ra.org |
ALTRA 19-1150 Kevin Deane, MD | To learn about the immune system and microbiome in individuals at risk for developing RA | Individuals with a positive blood test (anti-CCP antibody) or their close relatives (parents, siblings, children) | 303-724-8330 Or email rastudies@cuanschutz.edu Or visit website: www.altraproject.org |
| FIERA Female Influences on the Etiology of Rheumatoid Arthritis (FIERA) Study 14-1751 Kristen Demoruelle, MD, PhD | An observational study to identify the female genital tract as a potential mucosal site of initiation of autoimmunity in rheumatoid arthritis (RA). | At least 18 years old and is diagnosed with RA or has a parent, sibling, or child who is diagnosed with RA | 303-724-7594, or email Ju Young Kwag |
| SPARO Sputum Studies of Anti-Citrullinated Protein Antibodies (ACPA) and Rheumatoid Arthritis (RA) Origins [SPARO] 20-0206 Kristen Demoruelle, MD, PhD | An observational study to investigate the lung as a potential site where rheumatoid arthritis (RA) is developed. | At least 18 years old Falls under one of the following criteria: 1) has a parent, sibling, or child who is diagnosed with RA 2) has a clinically confirmed RA diagnosis 3) no personal or family history of RA | 303-724-7594, or email Ju Young Kwag |
Please note that study status changes frequently and therefore, a listed study may not be actively enrolling. Also, the complete list of inclusion and exclusion criteria for a given study is often not listed due to its length. A visit to determine an individuals eligibility may be required. A placebo is an inactive substance or treatment that looks the same as, and is given the same way as, an active drug or treatment being tested. The effects of the active drug or treatment are compared to the effects of the placebo.